Diagnosis and treatment of acromegaly

Growth Hormone and IGF Research

Volumn 15, Issue SUPPL., 2005, Pages 31-35

  Katznelson, Laurence ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acromegaly; Clinical presentation; Growth hormone; Review; Treatment

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; GROWTH HORMONE; LONG ACTING DRUG; OCTREOTIDE; PEGVISOMANT; PLACEBO; SHORT ACTING DRUG; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5;

ABDOMINAL PAIN; ACROMEGALY; ARTICLE; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RELEASE; EARLY DIAGNOSIS; GALLSTONE; GASTROINTESTINAL SYMPTOM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEADACHE; HORMONE ACTION; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; MORBIDITY; MORTALITY; MUSCULOSKELETAL DISEASE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PATIENT CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOTHERAPY; SLEEP APNEA SYNDROME; TRANSSPHENOIDAL SURGERY;

EID: 22744440855     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2005.06.007     Document Type: Article

References (34)

1. L. Alexander D. Appleton R. Hall W.M. Ross R. Wilkinson Epidemiology of acromegaly in the Newcastle region Clin. Endocrinol. 12 1980 71-99
2. S. Ezzat M.J. Forster P. Berchtold et al. Acromegaly: Clinical and biochemical features in 500 patients Medicine 73 1994 233-240
3. M.E. Molitch Clinical manifestations of acromegaly Endocrinol. Metab. Clin. North Am. 21 1992 597-614
4. S. Fazio A. Cittadini A. Cuocolo et al. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly J. Clin. Endocrinol. Metab. 79 1994 441-446
5. R.R. Grunstein K.Y. Ho C.E. Sullivan Sleep apnea in acromegaly Ann. Int. Med. 115 1991 527-532
6. R.R. Grunstein K.K. Ho C.E. Sullivan Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly Ann. Int. Med. 121 1994 478-483
7. E. Ron G. Gridley Z. Hrubec et al. Acromegaly and gastrointestinal cancer Cancer 68 1991 67-69
8. B. Delhougne C. Deneux R. Abs et al. The prevalence of colonic polyps in acromegaly: A colonoscopic and pathological study in 103 patients J. Clin. Endocrinol. Metab. 80 1995 3223-3226
9. B.A. Bengtsson S. Eden I. Ernest A. Oden B. Sjogren Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984 Acta Med. Scand. 223 1988 327-335
10. B. Swearingen F.G. Barker 2nd L. Katznelson et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly J. Clin. Endocrinol. Metab. 83 1998 3419-3426
11. A. Abosch J.B. Tyrrell K.R. Lamborn L.T. Hannegan C.B. Applebury C.B. Wilson Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results J. Clin. Endocrinol. Metab. 83 1998 3411-3418
12. A.S. Bates W. Van't Hoff J.M. Jones R.N. Clayton An audit of outcome of treatment in acromegaly Q. J. Med. 86 1993 293-299
13. M.O. Thorner M.L. Vance Growth hormone J. Clin. Invest. 82 1988 745-747
14. S. Melmed F.F. Casanueva F. Cavagnini et al. Guidelines for acromegaly management J. Clin. Endocrinol. Metab. 87 2002 4054-4058
15. P.M. Black N.T. Zervas G.L. Candia Incidence and management of complications of transsphenoidal operation for pituitary adenomas Neurosurgery 20 1987 920-924
16. R. Fahlbusch J. Honegger M. Buchfelder Surgical management of acromegaly [review] Endocrinol. Metab. Clin. North Am. 21 1992 669-692
17. P.U. Freda S.L. Wardlaw K.D. Post Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly J. Neurosurg. 89 1998 353-538
18. J.S. Powell S.L. Wardlaw K.D. Post P.U. Freda Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure J. Clin. Endocrinol. Metab. 85 2000 2068-2071
19. N.R. Biermasz H. van Dulken F. Roelfsema Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly J. Clin. Endocrinol. Metab. 85 2000 2476-2482
20. A.M. Landolt D. Haller N. Lomax et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly: Comparison with fractionated radiotherapy J. Neurosurg. 88 1998 1002-1008
21. M.D. Littley S.M. Shalet C.G. Beardwell S.R. Ahmed G. Applegate M.L. Sutton Hypopituitarism following external radiotherapy for pituitary tumours in adults Q. J. Med. 70 1989 145-160
22. C.B. Newman S. Melmed P.J. Snyder et al. Safety and efficacy of long-term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - a clinical research center study J. Clin. Endocrinol. Metab. 80 1995 2768-2775
23. M. Giusti E. Ciccarelli D. Dallabonzana et al. Clinical results of long-term slow-release lanreotide treatment of acromegaly Eur. J. Clin. Invest. 27 1997 277-284
24. P.H. Davies S.E. Stewart L. Lancranjan M.C. Sheppard P.M. Stewart Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly Clin. Endocrinol. (Oxf) 48 1998 311-316
25. A. Colao D. Ferone S. Lastoria et al. Prediction of efficacy of octreotide therapy in patients with acromegaly J. Clin. Endocrinol. Metab. 81 1996 2356-2362
26. J.S. Bevan The antitumoral effects of somatostatin analog therapy in acromegaly J. Clin. Endocrinol. Metab. 90 2005 1856-1863
27. A. Saveanu E. Lavaque G. Gunz et al. Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells J. Clin. Endocrinol. Metab. 87 2002 5545-5552
28. A. Colao D. Ferone P. Marzullo et al. Effect of different dopaminergic agents in the treatment of acromegaly J. Clin. Endocrinol. Metab. 82 1997 518-523
29. R. Abs J. Verhelst D. Maiter et al. Cabergoline in the treatment of acromegaly: A study in 64 patients J. Clin. Endocrinol. Metab. 83 1998 374-378
30. J.J. Kopchick C. Parkinson E.C. Stevens P.J. Trainer Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly Endocr. Rev. 23 2002 623-646
31. P.J. Trainer W.M. Drake L. Katznelson et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant N. Engl. J. Med. 342 2000 1171-1177
32. A.J. van der Lely R.K. Hutson P.J. Trainer et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist Lancet 358 2001 1754-1759
33. V.S. Herman-Bonert K. Zib J.A. Scarlett S. Melmed Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs J. Clin. Endocrinol. Metab. 85 2000 2958-2961
34. A.J. van der Lely A. Muller J.A. Janssen et al. Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient J. Clin. Endocrinol. Metab. 86 2001 478-481